Electromed develops, manufactures, and markets innovative airway clearance products that help people around the world breathe better, stay healthier, and lead active and fulfilling lives.
Our SmartVest Airway Clearance System is uniquely designed to make therapy easier and more comfortable to promote consistent therapy adherence.
We embrace the absolute therapeutic imperative of clearing excess mucus from the lungs. We listen intently to users, caregivers, and healthcare professionals alike to gain insights and inspiration for future product and service innovations that improve quality of life.
Each of our products is designed, engineered, and manufactured in Minnesota, a state widely known as a global leader in medical device innovation.
Introduced first portable HFCWO device
Created first machine-washable vest garment
Invented the first programmable HFCWO device
Developed the first multi-positional generator
Designed the industry’s smallest, quietest, and lightest generator
Launched wireless connectivity and patient communication platform
We are committed to helping those with impaired airway clearance through innovation and outstanding customer service.
A leader in transforming organizations through product innovation, quality initiatives, and improved productivity.
An advocate of a strategic vision to increase long-term shareholder value through responsible fiscal planning and reporting.
A specialist in developing high-performing sales teams that deliver sustainable growth and profit.
An innovator and strategic leader who engages with others to improve and create new service opportunities.
As a leading HFCWO device, SmartVest is featured in the press for its innovative technologies and dedication to helping people with impaired airway clearance.
Kathryn Thompson will oversee all reimbursement, billing, and contracting functions for the Company.
The bronchiectasis advisory board will serve as a key strategic resource to advance bronchiectasis awareness.
SmartVest Connect helps healthcare teams and patients better collaborate in making patient-centered care decisions.
Electromed Inc. has formed a bronchiectasis advisory board composed of three renowned experts in pulmonary medicine, according to a company announcement.
Electromed recently launched a SmartVest Connect wireless technology to complement the SmartVest SQL, a technology that allows doctors and patients with certain lung diseases, such as cystic fibrosis or bronchiectasis, to have access to treatment information and collaborate in care decisions.
Electromed recently launched its SmartVest Connect wireless technology, to be used with the SmartVest SQL, offering built-in cellular connectivity for healthcare teams and patients to quickly access information that allows for more personalized care decisions.
We’re always on the lookout for talented professionals to join our team of patient-centered employees.
SmartVest is thoughtfully designed to make therapy easier and promote adherence.
CA 2,357,737, 2,410,271, 2,541,333, 2,609,063, 2,712,704; DE 602007050125.3, 602008047083.0; HK 1054774, 1145625, IT 502016000131300, 502017000060742; JP 6030218, 5155329, 5327653; MX 341650; ZA 2006/9351, 2009/02798; KR 1471233; ES 07861771.9, 08836173.8; TW I428123; GB 2081625, 2200556; US 6,254,556, 6,676,614, 7,278,978, 7,537,575, 7,713,219, 7,736,324, 7,770,479, 8,197,428, 8,202,237, 8,740,824, 9,289,350, D531,728, D547,718, D585,991, D639,954, D697,197, D742,013
Additional patents may be pending in the U.S. and elsewhere.
The Electromed Investor Portal contains the latest financial information, events, presentations, corporate governance documents, and other investor relations services.